LIFECORE BIOMEDICAL, INC. Deferred Income Tax Expense (Benefit)
LIFECORE BIOMEDICAL, INC. (LFCR) reported Deferred Income Tax Expense (Benefit) of $155.00 thousand for the 7-month period ending 2025-12-31, per its 10-KT filed 2026-03-16.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-03-16
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for the quarter ending 2018-05-27 was $2.40M.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for the quarter ending 2018-02-25 was -$10.42M, a 1030.27% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for the quarter ending 2017-11-26 was $214.00K, a 63.73% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for the quarter ending 2017-08-27 was $1.15M, a 33.41% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for fiscal 2025 was -$119.00K, a 176.28% decline from fiscal 2024.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for fiscal 2024 was $156.00K, a 38.58% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for fiscal 2023 was $254.00K.
- LIFECORE BIOMEDICAL, INC. deferred income tax expense (benefit) for fiscal 2022 was -$5.59M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 3 month as first filed | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 7 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $155.00K 10-KT · filed 2026-03-16 | ||||||
| 2025-05-25 | -$119.00K 10-KT · filed 2026-03-16 | ||||||
| 2024-05-26 | $156.00K 10-KT · filed 2026-03-16 | ||||||
| 2023-05-28 | $254.00K 10-K · filed 2024-08-26 | ||||||
| 2022-05-29 | -$5.59M 10-K · filed 2024-08-26 | -$6.22M 10-K · filed 2022-09-14 | |||||
| 2021-05-30 | -$6.44M 10-K · filed 2024-03-20 | -$7.89M 10-K · filed 2021-07-29 | |||||
| 2020-05-31 | -$1.15M 10-K/A · filed 2023-03-16 | -$5.37M 10-K · filed 2020-08-14 | |||||
| 2019-05-26 | $1.44M 10-K · filed 2021-07-29 | ||||||
| 2018-05-27 | $2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | -$8.02M derived: sum of 2 quarters · filed 2020-08-14 | -$7.80M derived: sum of 3 quarters · filed 2020-08-14 | -$6.65M 10-K · filed 2020-08-14 | |||
| 2018-02-25 | -$10.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | -$10.21M derived: sum of 2 quarters · filed 2018-04-05 | -$9.05M 10-Q · filed 2018-04-05 | -$9.96M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2017-11-26 | $214.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $1.36M 10-Q · filed 2018-01-05 | $458.00K derived: sum of 3 quarters · filed 2019-08-01 | $1.58M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2017-08-27 | $1.15M 10-Q · filed 2017-09-28 | $244.00K derived: sum of 2 quarters · filed 2019-08-01 | $1.36M derived: sum of 3 quarters · filed 2019-08-01 | $1.95M derived: sum of 4 quarters · filed 2019-08-01 | |||
| 2017-05-28 | -$906.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $214.00K derived: sum of 2 quarters · filed 2019-08-01 | $804.00K derived: sum of 3 quarters · filed 2019-08-01 | $2.53M 10-K · filed 2019-08-01 | $2.51M 10-K · filed 2017-08-11 | ||
| 2017-02-26 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $1.71M derived: sum of 2 quarters · filed 2018-04-05 | $3.44M 10-Q · filed 2018-04-05 | $4.22M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2016-11-27 | $590.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $2.32M 10-Q · filed 2018-01-05 | $3.10M derived: sum of 3 quarters · filed 2018-08-09 | -$8.63M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2016-08-28 | $1.73M 10-Q · filed 2017-09-28 | $2.51M derived: sum of 2 quarters · filed 2018-08-09 | -$9.22M derived: sum of 3 quarters · filed 2018-08-09 | -$8.56M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2016-05-29 | $784.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | -$10.94M derived: sum of 2 quarters · filed 2018-08-09 | -$10.29M derived: sum of 3 quarters · filed 2018-08-09 | -$9.78M 10-K · filed 2018-08-09 | -$9.79M 10-K · filed 2016-08-01 | ||
| 2016-02-28 | -$11.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | -$11.07M derived: sum of 2 quarters · filed 2017-04-07 | -$10.56M 10-Q · filed 2017-04-07 | -$10.72M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-11-29 | $658.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $1.17M 10-Q · filed 2017-01-05 | $1.01M derived: sum of 3 quarters · filed 2018-03-15 | $3.90M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-08-30 | $509.00K 10-Q · filed 2016-09-29 | $348.00K derived: sum of 2 quarters · filed 2018-03-15 | $3.25M derived: sum of 3 quarters · filed 2018-03-15 | $4.23M derived: sum of 4 quarters · filed 2018-03-15 | |||
| 2015-05-31 | -$161.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $2.74M derived: sum of 2 quarters · filed 2018-03-15 | $3.72M derived: sum of 3 quarters · filed 2018-03-15 | $4.15M 10-K/A · filed 2018-03-15 | |||
| 2015-03-01 | $2.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $3.88M derived: sum of 2 quarters · filed 2016-03-30 | $4.31M 10-Q · filed 2016-03-30 | $4.61M derived: sum of 4 quarters · filed 2016-08-01 | |||
| 2014-11-30 | $986.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $1.42M 10-Q · filed 2016-01-07 | $1.71M derived: sum of 3 quarters · filed 2016-08-01 | $2.95M derived: sum of 4 quarters · filed 2016-08-01 | |||
| 2014-08-31 | $429.00K 10-Q · filed 2015-10-01 | $728.00K derived: sum of 2 quarters · filed 2016-08-01 | $1.96M derived: sum of 3 quarters · filed 2016-08-01 | $3.71M derived: sum of 4 quarters · filed 2016-08-01 | |||
| 2014-05-25 | $299.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $1.53M derived: sum of 2 quarters · filed 2016-08-01 | $3.28M derived: sum of 3 quarters · filed 2016-08-01 | $5.58M 10-K · filed 2016-08-01 | $5.61M 10-K · filed 2014-08-01 | ||
| 2014-02-23 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $2.98M derived: sum of 2 quarters · filed 2015-04-02 | $5.29M 10-Q · filed 2015-04-02 | $7.66M derived: sum of 4 quarters · filed 2015-07-31 | |||
| 2013-11-24 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $4.05M 10-Q · filed 2015-01-09 | $6.43M derived: sum of 3 quarters · filed 2015-07-31 | $7.62M derived: sum of 4 quarters · filed 2015-07-31 | |||
| 2013-08-25 | $2.30M 10-Q · filed 2014-10-08 | $4.68M derived: sum of 2 quarters · filed 2015-07-31 | $5.87M derived: sum of 3 quarters · filed 2015-07-31 | $6.97M derived: sum of 4 quarters · filed 2015-07-31 | |||
| 2013-05-26 | $2.38M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $3.57M derived: sum of 2 quarters · filed 2015-07-31 | $4.66M derived: sum of 3 quarters · filed 2015-07-31 | $6.61M 10-K · filed 2015-07-31 | $6.51M 10-K · filed 2013-08-07 | ||
| 2013-02-24 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $2.29M derived: sum of 2 quarters · filed 2014-03-28 | $4.23M 10-Q · filed 2014-03-28 | $7.36M derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-11-25 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $3.04M 10-Q · filed 2014-01-03 | $6.17M derived: sum of 3 quarters · filed 2014-08-01 | $6.79M derived: sum of 4 quarters · filed 2014-08-01 | |||
| 2012-08-26 | $1.94M 10-Q · filed 2013-09-26 | $869.00K 10-Q · filed 2012-10-03 | $5.07M derived: sum of 2 quarters · filed 2014-08-01 | $5.69M derived: sum of 3 quarters · filed 2014-08-01 | $5.52M derived: sum of 4 quarters · filed 2014-08-01 | ||
| 2012-05-27 | $3.13M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $3.75M derived: sum of 2 quarters · filed 2014-08-01 | $3.58M derived: sum of 3 quarters · filed 2014-08-01 | $3.28M 10-K · filed 2014-08-01 | |||
| 2012-02-26 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $456.00K derived: sum of 2 quarters · filed 2013-04-04 | $157.00K 10-Q · filed 2013-04-04 | $2.18M derived: sum of 4 quarters · filed 2013-08-07 | |||
| 2011-11-27 | -$164.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | -$463.00K 10-Q · filed 2013-01-04 | $1.56M derived: sum of 3 quarters · filed 2013-08-07 | ||||
| 2011-08-28 | -$299.00K 10-Q/A · filed 2013-01-02 | $1.72M derived: sum of 2 quarters · filed 2013-08-07 | |||||
| 2011-05-29 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $3.26M 10-K · filed 2013-08-07 | |||||
| 2011-02-27 | $1.24M 10-Q · filed 2012-03-28 | ||||||
| 2010-11-28 | $737.00K 10-Q · filed 2012-01-05 | ||||||
| 2010-08-29 | $375.00K 10-Q · filed 2011-10-05 | ||||||
| 2010-05-30 | $3.25M 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |